JOINT FILING AGREEMENTJoint Filing Agreement • February 3rd, 2020 • Vivo Capital IX, LLC • Pharmaceutical preparations
Contract Type FiledFebruary 3rd, 2020 Company IndustryIn accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, no par value, of Trillium Therapeutics, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing.